Brain-Delivered Antibody Targets Alpha-Synuclein Aggregates
In a groundbreaking advancement poised to revolutionize the treatment of neurodegenerative disorders, researchers have unveiled a novel brain-shuttled antibody designed specifically to target alpha-synuclein aggregates—a...